At Accenture, our clients, partners and employees are our top priority. Over the past few weeks, we have been closely monitoring the COVID-19 situation. We are following direction from international health organizations, local governments as well as our own safety and security protocols, and actively monitoring the situation through a network of outside experts and organizations that provide us real-time information. Based on our latest assessment, we have made the difficult but important decision to postpone our Life Sciences HealthTech Innovation Challenge.
While we are disappointed that we will not be together in Chicago, Zurich, Boston, San Francisco and Shanghai, we believe that this is the right decision given the current circumstances. Once the situation has stabilized, we will share additional information and next steps (or future plans) for our global HealthTech Innovation Challenge events.
All startup applications submitted from January 27 until February 29, 2020 will be retained and reviewed as planned. Once we determine next steps for our events, startups shortlisted will be informed three weeks prior to each event.
We appreciate your flexibility and support during this time, and our thoughts remain with everyone affected by the COVID-19 situation.
We look forward to connecting with you soon.